| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |